Andrews, Peter W. http://orcid.org/0000-0001-7215-4410
Funding for this research was provided by:
Medical Research Council (MR/V002163/1, MR/L012537/1)
H2020 European Institute of Innovation and Technology (H2020-FETPROACT-2018-01)
Article History
Received: 15 January 2024
Accepted: 31 January 2024
First Online: 23 February 2024
Declarations
:
: PWA receives Royalties from the Wistar Institute from sales of the TRA series of antibodies and is a member of the SAB of TreeFrog Therapeutics.